entertainment -WSS

entertainment

author：focus 2025-08-19 15:01:29 - browse：8481

a person wearing blue dress conducts a finger prick test on another person in a home setting — coverage from STAT — Adobe

The last decade has seen billions of dollars flow into digital health companies that promise to improve outcomes for the 38 million Americans living with type 2 diabetes. Their products aren’t cheap, but in the long term, they pitch to health plans and employers that these digital tools will help cut health care costs by preventing serious complications like amputation and kidney failure.

A systematic review by the Peterson Health Technology Institute found, though, that digital tools used to manage diabetes with the help of finger-stick blood glucose readings don’t result in clinically meaningful improvements over standard care. As a result, they don’t reduce health care spending — they drive it up.

“Most of the solutions in this category do not deliver clinical benefits that justify their cost,” Caroline Pearson, executive director of the institute, told STAT. Despite finding that some populations may benefit, the report concludes that current evidence doesn’t support broader adoption for most products.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： 'Null' research findings aren't empty of meaning. Let's publish them

Wikipedia

WSS

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Healthy food access boosts outcomes in two studies

FDA scientists endorse Pfizer/BioNTech Covid

When waiting feels immoral: Empathy in the emergency department

Today's health inequities arise from racist U.S. history, say experts

Personalized medicine goes far beyond genetics

entertainment

entertainment

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

A controversial new treatment promises to make little people taller

United colonoscopy coverage change 'may cost lives,' doctors say

After decades in use, heart stents finally beat placebo

Wildfire smoke exposes gaps in outdoor worker protections

Physicians aren't 'burning out.' They're suffering from moral injury

United colonoscopy coverage change 'may cost lives,' doctors say

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Dobbs anniversary: the lost opportunity of abortion as health care

Medical school prerequisites are outdated

focus

Healthy food access boosts outcomes in two studies

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Heart disease in astronauts blamed on cosmic radiation

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

What health policies could hitch a ride on a spending bill?

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

entertainment

Wikipedia

entertainment

focus